Advertisement
Screener

INOGEN, INC. (INGN) Stock Issued During Period, Value, Employee Stock Purchase Plan

2.8 / 5 stars · 68/120 Roast Me

INOGEN, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-12-31 was $0.00.
  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-09-30 was $464.00K, a 40.21% decline year-over-year.
  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $0.00.
  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-03-31 was $630.00K, a 31.15% decline year-over-year.
  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.09M, a 35.30% decline from fiscal 2022.
  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.69M, a 13.19% decline from fiscal 2021.
  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $1.95M, a 6.53% decline from fiscal 2020.
  • INOGEN, INC. stock issued during period, value, employee stock purchase plan for fiscal 2020 was $2.08M, a 24.16% decline from fiscal 2019.
Period endStock Issued During Period, Value, Employee Stock Purchase Plan 3 monthStock Issued During Period, Value, Employee Stock Purchase Plan 12 month
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$1.09M
10-K · filed 2026-02-27
2023-09-30$464.00K
10-Q · filed 2024-11-08
$1.09M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$1.41M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$630.00K
10-Q · filed 2024-05-08
$1.41M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$1.69M
10-K · filed 2025-02-28
2022-09-30$776.00K
10-Q · filed 2023-11-09
$1.69M
derived: sum of 4 quarters · filed 2024-03-01
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$1.94M
derived: sum of 4 quarters · filed 2024-03-01
2022-03-31$915.00K
10-Q · filed 2023-05-05
$1.94M
derived: sum of 4 quarters · filed 2024-03-01
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
$1.95M
10-K · filed 2024-03-01
2021-09-30$1.02M
10-Q · filed 2022-11-03
$1.95M
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$1.92M
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31$927.00K
10-Q · filed 2022-05-05
$1.92M
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$2.08M
10-K · filed 2023-02-24
2020-09-30$996.00K
10-Q · filed 2021-11-04
$2.08M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$2.31M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$1.09M
10-Q · filed 2021-05-04
$2.31M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$2.75M
10-K · filed 2022-02-24
2019-09-30$1.22M
10-Q · filed 2020-11-04
$2.75M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$2.88M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$1.52M
10-Q · filed 2020-05-05
$2.88M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$2.35M
10-K · filed 2021-02-24
2018-09-30$1.36M
10-Q · filed 2019-11-05
$2.35M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$1.79M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$988.00K
10-Q · filed 2019-05-07
$1.79M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.38M
10-K · filed 2020-02-25
2017-09-30$798.00K
10-Q · filed 2018-11-06
$1.38M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$1.14M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$581.00K
10-Q · filed 2018-04-30
$1.14M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$1.05M
10-K · filed 2019-02-26
2016-09-30$555.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$1.05M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$859.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$500.00K
10-Q · filed 2017-05-09
$859.00K
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$701.00K
10-K · filed 2018-02-27
2015-09-30$359.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$701.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
2015-03-31$342.00K
10-Q · filed 2015-05-12
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$413.00K
10-K · filed 2017-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B